Skip to main content
PAS 2024 Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner
Back
Evaluation ViewAttendees 48
Clubs

Basic Science

Breastfeeding/Human Milk

Clinical Research

Developmental Biology

Genomics/Epigenomics

Global Neonatal & Children's Health

Neonatology

Pediatric Nutrition
Session Type: Clubs in Convention Center

Perinatal Nutrition and Metabolism Club

Monday, May 6, 2024
11:30 AM – 1:00 PM ET
Location: Metro Toronto Convention Centre: 203
CE: Live CME: 1.5

    Chair(s)

  • Cynthia Blanco, MD

    Professor of Pediatrics
    Pediatrics
    The University of Texas Health Science Center at San Antonio Joe R. and Teresa Lozano Long School of Medicine
    San Antonio, Texas, United States

  • Mandy Belfort, MD, MPH (she/her/hers)

    Attending Neonatologist and Associate Professor of Pediatrics
    Pediatric Newborn Medicine
    Harvard Medical School
    Boston, Massachusetts, United States

  • Gustave Falciglia, MD MSCI MSHQPS

    Assistant Professor of Pediatrics
    Northwestern University, Feinberg School of Medicine
    Chicago, Illinois, United States

Disclosure(s):
Cynthia Blanco, MD: Prolacta bioscience (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)
Mandy Belfort, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Gustave H. Falciglia, MD MSCI MSHQPS: Medical Predictive Science Corporation (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

Session

Description: Preterm birth abruptly interrupts third trimester maternal-fetal transfer of PUFAs such as DHA and arachidonic acid (ARA). PUFAs serve as critical building blocks for brain and eye development and modulate inflammation, with important health consequences when dietary intake is limited. Substantial evidence exists regarding PUFA supplementation in pregnancy and postnatally for preterm infants and suggests both benefits and potential harms, with uncertainty about overall long-term clinical benefit. This session will review, synthesize, and critique existing evidence regarding PUFA supplementation in the perinatal period, including a focus on commercially available supplements as well as opportunities for future therapeutics based on emerging science.

Learning Objectives:

  • Describe existing evidence on perinatal Docosahexaenoic acid (DHA) and other polyunsaturated fatty acid (PUFA) supplementation, including both short- and long-term benefits and risks to health.
  • Discuss current approach to evaluating fatty acid status at different stages of infant development and challenges with various methodologies.
  • Overview randomized controlled trials with evidence-based discussion of risk/benefit. Highlight key knowledge gaps that limit optimal perinatal fatty acid supplementation strategies and summarize contemporary approach.

Presentations:

  • 11:30 AM – 2:00 AM ET
    Fatty Acids in the Perinatal Period, a Path for Evidence Based Supplementation

    Speaker: Camilia Martin, MD. MS (she/her/hers) – Weill Cornell Medicine